Modulation of sphingosine-1-phosphate in ulcerative colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Modulation of sphingosine-1-phosphate in ulcerative colitis

Published:2020-02-25 Issue:4 Volume:20 Page:413-420
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Argollo Marjorie¹²^ORCID,Furfaro Federica²,Gilardi Daniela²,Roda Giulia²,Allocca Mariangela²³,Peyrin-Biroulet Laurent⁴,Danese Silvio²³^ORCID

Affiliation:

1. Department of Gastroenterology, Universidade Federal de São Paulo, São Paulo, Brazil

2. IBD Centre, Humanitas Clinical and Research Centre, Milan, Italy

3. Department of Biomedical Sciences, Humanitas University, Milan, Italy

4. Department of Gastroenterology and Inserm U954, Nancy University Hospital, Lorraine University, Vandoeuvre, France

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1732919

Reference39 articles.

1. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

2. Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis

3. Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

4. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

5. Next generation of small molecules in inflammatory bowel disease

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials;Journal of Gastroenterology;2024-07-09

2. Development and validation of stability-indicating method of etrasimod by HPLC/DAD/MS/MS technique with greenness profiling;Heliyon;2024-07

3. The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical Program;Inflammatory Bowel Diseases;2024-06-20

4. Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials;Journal of Crohn's and Colitis;2024-06-15

5. 1-Phosphate receptor agonists: A promising therapeutic avenue for ischemia-reperfusion injury management;International Immunopharmacology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3